Campbell & Co Investment Adviser’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Buy |
10,193
+88
| +0.9% | +$1.51K | 0.01% | 1070 |
|
|
2025
Q1 | $645K | Buy |
10,105
+6,275
| +164% | +$400K | 0.05% | 581 |
|
|
2024
Q4 | $466K | Buy |
+3,830
| New | +$466K | 0.04% | 689 |
|
|
2024
Q3 | – | Sell |
-7,135
| Closed | -$1.13M | – | 1315 |
|
|
2024
Q2 | $1.13M | Buy |
+7,135
| New | +$1.13M | 0.1% | 317 |
|
|
2024
Q1 | – | Sell |
-4,454
| Closed | -$429K | – | 1350 |
|
|
2023
Q4 | $429K | Buy |
+4,454
| New | +$429K | 0.04% | 787 |
|
|
2023
Q2 | – | Sell |
-4,537
| Closed | -$625K | – | 1103 |
|
|
2023
Q1 | $625K | Sell |
4,537
-1,572
| -26% | -$217K | 0.12% | 327 |
|
|
2022
Q4 | $792K | Buy |
6,109
+3,977
| +187% | +$515K | 0.19% | 148 |
|
|
2022
Q3 | $236K | Buy |
+2,132
| New | +$236K | 0.05% | 561 |
|
|
2021
Q3 | – | Sell |
-2,917
| Closed | -$227K | – | 759 |
|
|
2021
Q2 | $227K | Buy |
+2,917
| New | +$227K | 0.09% | 410 |
|
|
2019
Q4 | – | Sell |
-6,703
| Closed | -$505K | – | 834 |
|
|
2019
Q3 | $505K | Buy |
+6,703
| New | +$505K | 0.19% | 170 |
|
|
2018
Q3 | – | Sell |
-2,409
| Closed | -$318K | – | 517 |
|
|
2018
Q2 | $318K | Sell |
2,409
-3,000
| -55% | -$396K | 0.24% | 174 |
|
|
2018
Q1 | $401K | Buy |
+5,409
| New | +$401K | 0.34% | 94 |
|